feedback

Course Director

Eric S. Rovner, MD

Section of Voiding Dysfunction, Female Urology and Urodynamics
Department of Urology
Medical University of South Carolina
Charleston, South Carolina

Faculty

Christopher Chapple

Alan Wein

Accredited by

American Urological Association

Course Description

After completing this activity, participants will be able to:

1. Define the similarities and differences between the various oral pharmacotherapies for overactive bladder (OAB).
2. Review the principles of physiology and pharmacotherapy for currently available agents, including the antimuscarinics and beta-3 agonists and combination therapy.
3. Describe the importance of setting proper patient expectations regarding treatment of OAB and the potential need for sequential and even additive therapies.
4. Analyze the clinical (and theoretical) advantages and limitations of currently available agents.
5. Review potential future pharmacological pathways and therapies for OAB.

Activity Details

Credit Types:CME
Credit Amount:2.00 Credits
Release Date:2019-May-06
Expiration Date:2020-May-06
Estimated Time for Completion:2 hours
Registration Required:Yes
Cost:Free

Suggest a CME Activity

Please provide below the URL and description of an activity you would like to add to OpenCME. You are welcome to add activities as often as you like. To prevent spam or other abuse, activities are reviewed by our editorial team before appearing on OpenCME.

OpenCME for Publishers

Please use the form below if you would like to offer your website visitors high-quality CME content by adding the OpenCME Widget to one or more of your pages.

Send Email to a Colleague

To share this activity with one or more colleagues, enter their e-mail addresses below. To include a personal message, simply overwrite the suggested text below.

(So your recipient knows it's from you.)
Enter multiple recipients separated by a space.
Optionally, replace/modify in the box above the message that will be sent to your colleague(s) with a link to download this app.